US Stock MarketDetailed Quotes

CME CME Group

Watchlist
  • 229.450
  • +0.250+0.11%
Close Jan 13 16:00 ET
  • 229.450
  • 0.0000.00%
Post 20:01 ET
82.68BMarket Cap24.13P/E (TTM)

CME Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CME Group Q4 2024 Estimates Date

Currency：USDFeb 12, 2025

Estimate YoY
Revenue
1.52B
+5.38%
EPS
2.34
+4.51%
Analyst Rating
Hold

Jan 13, 2025

CME Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.541B--
Feb 12, 20252024/Q4-- / 1.517B--
Oct 23, 20242024/Q31.584B / 1.594B--
Jul 24, 20242024/Q21.533B / 1.529B--
Apr 24, 20242024/Q11.488B / 1.475B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.541B--
Feb 12, 20252024/Q4-- / 1.517B--
Oct 23, 20242024/Q31.584B / 1.594B--
Jul 24, 20242024/Q21.533B / 1.529B--
Apr 24, 20242024/Q11.488B / 1.475B--

Unlock Free Earnings Estimates

CME Group Earnings Reports

  • CME Group | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 15:25 ET

  • CME Group | 10-Q: Q2 2024 Earnings Report

    Aug 5, 2024 16:53 ET

  • CME Group | 10-Q: Q1 2024 Earnings Report

    May 1, 2024 13:57 ET

  • CME Group | 8-K: FOR IMMEDIATE RELEASE CME Group Inc. Reports First-Quarter 2024 Financial Results

    Apr 24, 2024 07:08 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +4.06%
    DexCom
    DXCM
    +2.67%
    Collegium Pharmaceutical
    COLL
    +2.67%
    Halozyme Therapeutics
    HALO
    +2.54%
    Constellation Brands
    STZ
    +2.26%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 13, 2025

    Hold

    • Buy

      18.18%

    • Hold

      63.64%

    • Sell

      18.18%

    Price Target

    No Data